Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was ...
Plus: Why Mike Pence is opposing RFK Jr.’s nomination{beacon} Health Care Health Care   The Big Story Kennedy’s HHS nod gets ...
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...
Shares in vaccine makers and healthcare firms around the world slid sharply on Friday, as investors warned that Donald ...
Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute
AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...
Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...
Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...
AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback